{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:49:19Z","timestamp":1769086159789,"version":"3.49.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1302,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Pulmonary artery pressure (PAP)-guided therapy in patients with heart failure (HF) using the CardioMEMS (CMM) device, an implantable PAP sensor, has been shown to reduce HF hospitalizations in previous studies. We sought to evaluate the clinical benefit of the CMM device in regard to 30, 90, and 180 day readmission rates in real-world usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We queried the Nationwide Readmissions Database (NRD) to identify patients who underwent CMM implantation (International Classification of Diseases 9 and 10 codes) between the years 2014 and 2019 and studied their HF readmissions. Moreover, we compared CMM patients and their readmissions with a matched cohort of patients with HF but without CMM. Multivariable Cox regression analysis was performed to adjust for other predictors of readmissions. Prior to matching, we identified 5 326 530 weighted HF patients without CMM and 1842 patients with CMM. After propensity score matching for several patients and hospital-related characteristics, the cohort consisted of 1839 patients with CMM and 1924 with HF without CMM. Before matching, CMM patients were younger (67.0 \u00b1 13.5 years vs. 72.3 \u00b1 14.1 years, P &amp;lt; 0.001), more frequently male (62.7% vs. 51.5%, P &amp;lt; 0.001), with higher rates of prior percutaneous coronary intervention (16.9% vs. 13.2%, P = 0.002), peripheral vascular disease (29.6% vs. 17.8%, P &amp;lt; 0.001), pulmonary circulatory disorder (38.7% vs. 23.2%, P &amp;lt; 0.001), atrial fibrillation (51.2% vs. 45.3%, P = 0.002), prior left ventricular assist device (1.8% vs. 0.2%, P &amp;lt; 0.001), high income (32.2% vs. 16.4%, P &amp;lt; 0.001), and acute kidney disease (43.8% vs. 29.9%, P &amp;lt; 0.001). Readmission rates at 30 days were 17.3% vs. 20.9% for patients with vs. without CMM, respectively, and remained statistically significant after matching (17.3% vs. 21.5%, P = 0.002). The rates of 90 day (29.6% vs. 36.5%, P = 0.002) and 180 day (39.6% vs. 46.6%, P = 0.009) readmissions were lower in the CMM group. In a multivariable regression model, CMM was associated with lower risk of readmissions (hazard ratio 0.75, 95% confidence interval 0.63\u20130.89, P = 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The CMM device was associated with reduced HF rehospitalization rates in a nationally representative cohort of HF patients, validating the clinical trial that led to the approval of this device and its utilization in the treatment of HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13956","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T05:59:06Z","timestamp":1652421546000},"page":"2511-2517","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Pulmonary Artery Pressure-Guided Therapy on Heart Failure Readmission in a Nationally Representative Cohort"],"prefix":"10.1093","volume":"9","author":[{"given":"Yoshikazu","family":"Kishino","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaqib H.","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg M.","family":"Lanier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Sims","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Ruiz Duque","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Section of Heart Failure and Transplantation, University of Iowa , Iowa, IA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Section of Heart Failure and Transplantation, University of Iowa , Iowa, IA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"2026012114142845100_ehf213956-bib-0001","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0002","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0003","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0004","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"2026012114142845100_ehf213956-bib-0006","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0007","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure-associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012114142845100_ehf213956-bib-0008","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0009","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2026012114142845100_ehf213956-bib-0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"2026012114142845100_ehf213956-bib-0011","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026012114142845100_ehf213956-bib-0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2020.10.004","article-title":"Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation","volume":"84","author":"Briasoulis","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2026012114142845100_ehf213956-bib-0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002600","article-title":"Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions","volume":"9","author":"Adamson","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101008","article-title":"Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity","volume":"38","author":"Lawson","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026012114142845100_ehf213956-bib-0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jamacardio.2019.0766","article-title":"Trends in readmissions and length of stay for patients hospitalized with heart failure in Canada and the United States","volume":"4","author":"Samsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026012114142845100_ehf213956-bib-0016","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2468-2667(19)30108-2","article-title":"20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study","volume":"4","author":"Lawson","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026012114142845100_ehf213956-bib-0017","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.111.018473","article-title":"Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study","volume":"123","author":"Koehler","year":"2011","journal-title":"Circulation"},{"key":"2026012114142845100_ehf213956-bib-0018","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","article-title":"Telemonitoring in patients with heart failure","volume":"363","author":"Chaudhry","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012114142845100_ehf213956-bib-0019","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchf.2015.12.015","article-title":"Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure","volume":"4","author":"Sandhu","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"key":"2026012114142845100_ehf213956-bib-0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006863","article-title":"Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study","volume":"13","author":"Shavelle","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0022","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.1943","article-title":"Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF)","volume":"22","author":"Angermann","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003594","article-title":"Intracardiac pressures measured using an implantable hemodynamic monitor relationship to mortality in patients with chronic heart failure","volume":"10","author":"Zile","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026012114142845100_ehf213956-bib-0024","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2017.08.010","article-title":"Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction","volume":"70","author":"Givertz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114142845100_ehf213956-bib-0025","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCHEARTFAILURE.109.923300","article-title":"Chronic ambulatory intracardiac pressures and future heart failure events","volume":"3","author":"Stevenson","year":"2010","journal-title":"Circ Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13956","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13956","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/4\/2511\/65349403\/eschf_9_4_2511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/4\/2511\/65349403\/eschf_9_4_2511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:17:11Z","timestamp":1769023031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/4\/2511\/8322932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,5,13]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13956","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"2021-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}